Charcoal Quality Assurance Common cold Phase I Spacious archive Statistical services DFI Safety Protocol development Phase II Patients Phase IIb trials CRO Steady state Healthy subjects Children IMPD Auditing Allergy Axis Pharmacodynamic studies Transdermal therapeutic system Oncological patients Oncologic network Drug Drug Interaction Database Thuringia Cough Macular PASS Postmenopausal women Design development Ophthalmologist Patient recruitment Biopharmaceutics Pituitary Phase I Unit Immunogenicity Phase IIa trials DUS Bioequivalence FDA Standardisation Hypothalamic Endpoint Consultancy SDV MCID Dose linearity Dry powder inhaler CDM IB NIS Central surveillance system Statistical Analysis Plan Standard operating procedure Oncology ICF Lung HPA axis Rhine Main area Inhalatives Local tolerability Dermal irritation WinNonlin Degeneration Pilot study Pragmatism Clinical Monitoring Copyright Patch TTS IVIVC Ophthalmological trials Bioavailability Ophthalmology Creativity Investigators brochure DDI Sample size estimation Metered dose inhaler MDI Drug Food Interaction Training Centralised procedure CRF SocraTec C&S Post authorisation GCP Efficacy Legal Information Network Informed Consent Procedure Data management DPI Sequential designs Quality Quality Management System Eye disease Adrenocortical EMA GCP training Monitoring Biosimilars Absorption windows Hormone replacement therapy Biopharmaceutical Ovulation inhibition CDSIC Statistical programming Authorities Referral system Highly variable drugs CDISC Legal representative Audit GLP Paediatricians Dry eye US CFR 21 Part 11 HRT Phase III Recruitment rates Clinical trials CDASH Ocular tolerability Asthma Contraception ANVISA PAES MMM Sensitisation trials Scientific expertise Early phase ADAM Competence Product development Glaucoma Sore throat Source Data Verification Patch adhesion US FDA Feasibility In vitro in vivo correlation Slit lamp microscopy HTA Pulse oximetry plethysmography Gynaecological trials IEC Clinical study Protocol Expert SAS CRA Clinical pharmacology unit Phase IV Pharmacology Cardiovascular surveillance First in human Intensive assessment station COPD Edema FIM SOP based Project Management Xerostomia Inspection OTC Non interventional Pharmacokintetics Elpro Uveitis Experience Scientific advice Anaesthesiologist Absorption Subcontractor qualification Female adolescents Life cycle management Clinical development program Biometrics Pharmacokinetics Data Management Plan Data Validation Plan Good Clinical Practice
Services
Box 0
Design Development
Box 1
Scientific Advice
Box 2
Project Management
Box 3
Quality Assurance (QA)
Box 4
Monitoring
Box 5
Clinical Performance
Box 6
Data Management / eTrials
Box 7
Biostatistics
Box 8
Medical Writing
Box 9
Expert Statement
Box 10
Expertise
Box 11
Pharmacokinetics
Box 12
Bioavailability / Bioequivalence
Box 13
Interactions
Box 14
Oncological trials
Box 15
Ophthalmological trials
Box 16
Inhalatives
Box 17
Transdermal Therapeutic Systems
Box 18
Children
Box 19
Sexual Hormones
Box 20
Therapeutic Expertise
Box 21
Clinical Development
Box 22
Phase I
Box 23
Phase II / Proof of Concept
Box 24
Phase III in OTC
Box 25
Phase III
Box 26
Non-Interventional
Box 27
Magnetic Marker Monitoring
Box 28
Medical Devices
Box 29
Nutrition Studies
Box 30
Clinical Pharmacology Unit
Box 31
Location Plan
Box 32
Capacity
Box 33
Technical Monitoring
Box 34
Ophthalmology
Box 35
Gynaecology
Box 36
Intensive Assessment Unit
Box 37
Clean Room Area
Box 38
Archive
Box 39
About Us
Box 40
Goals and Visions
Box 41
Our Experts
Box 42
Science
Box 43
Quality
Box 44
Library Presentations
Box 45
Library Publications
Box 46
Locations
Box 47
Career
Box 48
News
Box 49
Trial in drug-induced xerostomia published
Box 50
2nd Global Bioequivalence Harmonisation Initi...
Box 51
Routine GCP inspection successfully passed
Box 52
IMPORTANT NOTICE: CHRISTMAS CANCELLED!
Box 53
Virtual tour through our CPU now online
Box 54
Workshop: New Guideline on Modified Release P...
Box 55
Probanden
Box 56
The SocraTec Family
Box 57
SocraTec C&S
Box 58
SocraMetrics
Box 59
Cooperations
Box 60
Menu

All fine.